Paper by Marcus Dillender appears in Journal of Public Economics

Wednesday, August 15th, 2018

Marcus DillenderA paper by Institute senior economist Marcus Dillender appears in the latest issue of Journal of Public Economics. In "What happens when the insurer can say no? Assessing prior authorization as a tool to prevent high-risk prescriptions and to lower costs," Dillender estimates the effect of a prior authorization requirement for certain costly and abuse-prone drugs on prescription drug use and costs for work-related injuries in Texas. His findings indicate that the prior authorization requirement reduces the likelihood that claimants receive nonpreferred drugs as well as insurers' spending on nonpreferred drugs.

Access "What happens when the insurer can say no? Assessing prior authorization as a tool to prevent high-risk prescriptions and to lower costs."